AlveoliX AG

Swiss Biotech Association

Member

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

Location

Freiburgstrasse 3, 3010 Bern, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2019
Number of employees in Switzerland

10-19

Key business

Core competencies

You may also be interested in

CELLnTEC Advanced Cell Systems

CELLnTEC technologies enable science and industry to develop innovations in stem cell research, regenerative medicine, cell-based therapies, and beyond. The company is a pioneering developer of chemically defined, animal and human components-free precision media.
3014 Bern

Member

INCAPTEK Sàrl

We at INCAPTEK are developing advanced drug delivery systems. We deliver drugs at the right place, in the right dosage, and at the right time. Our smart, programmed-shell micro(nano)capsules can be used for controlled and targeted drug delivery for both biotech and medtech.
1204 Geneva

Member

Curare Swiss AG

Curare provides strategic advice to assist in the successful design of R&D programs. From the non-clinical to clinical Proof-of-Concept. The right decisions at the right time. Curare's experts put their years of experience and knowledge relating to translational and clinical drug development to use.
4056 Basel

Member